On December 22, 2025, Mustang Bio, Inc. held its annual meeting where they elected seven directors, ratified KPMG as auditors, and amended their stock plans to increase shares by 2.75 million. Additionally, they terminated a license agreement with Fred Hutch and agreed to pay $730,000 for outstanding payables.